Release Notes:
Release Notes
Version 2025B
This page does not need to be edited for each new release. The list of release notes is automatically generated based on the release identified in url param.
Release Notes for the ALC2025B Manual
| Section | Rationale | Description |
|---|
| No Measure Information Form release notes for the ALC2025B release. |
Data Elements
| Section | Rationale | Description |
|---|
| Off-Label Antipsychotic Drug Prescribed | Table updated to include a new antipsychotic medication which was approved in 2024. | Notes for abstraction:
Add to Atypical Antipsychotics
Cobenfy (xanomeline and trospium chloride)
Add to FDA Approved Uses
Schizophrenia (PO) |
Supplemental Materials
| Section | Rationale | Description |
|---|
| No Supplemental Material release notes for the ALC2025B release. |